Navigation Links
Enduring anti-clotting treatment avails heart patients

According to a new study, researchers have observed that patients who took aspirin and anti-clotting drugs for a year after angioplasty had a decreased risk of problems. Angioplasty involves inserting a balloon and then a device called a stent into a blocked coronary artery.// It's often life-saving, for it opens up the artery again. However, one complication that often occurs when such percutaneous coronary interventions (PCIs) take place is clotting.

Previous research has shown the advantage of tackling the clotting problem with aspirin and anti-clotting drugs given for a few weeks after the PCI. A new study now shows that giving the combination therapy for a whole year gives even better results.

Researchers at the University of North Carolina studied a group of over 1,500 patients receiving either the anti-clotting drug clopidogrel or placebo for a year after PCI. All of them also received aspirin. At the end of the study, there were significantly fewer adverse events, such as heart attack, clotting or need for further intervention, in the clopidogrel group. Researchers feel that what was less clear was the benefit of giving the drug before PCI as well - but it seems likely that this will help at least some patients.


'"/>




Page: 1

Related medicine news :

1. Bivalirudin, a new anti-clotting drug may be a safer option for treatment of acute coronary conditions
2. Thyroid hormone treatment hastens recovery after cardiac surgery
3. Feeding channel created by malaria parasite - a new target for malaria treatments
4. Now umbilical cord helps in stroke treatment.
5. Now AIDS treatment comes dirt-cheap
6. Breast cancer treatment to be determined by gene test
7. Hemopurifier may revolutionise AIDS treatment
8. New drug helps boost cancer treatment
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Experimental treatment for Ebola Virus Shows promising results in mice
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... The parent company ... in employee engagement. Omaha-based C&A Industries, a national leader in staffing and ... in North America for 2017. The annual award, issued by Achievers, ...
(Date:6/28/2017)... ... June 28, 2017 , ... Anyone with a remote control has seen the never-ending twists on ... the flipper will get rich in no time. But what about the buyers of ... for the buyer of a flipped house. An email recently sent to Gary Case ...
(Date:6/28/2017)... ... 2017 , ... Park Systems , a leader in Atomic Force Microscopy ... attendees and Park customers on July 11, 2017 from 12-2pm at the Thirsty Bear ... CEO of Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor in the ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, the ... the health care industry’s hospitals and provider groups, has announced that it will ... customers. Parasail Health is a San Francisco health-finance startup that has launched a ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: